- Home
- INM vs EQH Comparison
INM vs EQH Comparison
Compare INM & EQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- EQH
- Stock Information
- Founded
- INM 1981
- EQH 1859
- Country
- INM Canada
- EQH United States
- Employees
- INM N/A
- EQH N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- EQH Specialty Insurers
- Sector
- INM Health Care
- EQH Finance
- Exchange
- INM Nasdaq
- EQH Nasdaq
- Market Cap
- INM 3.2M
- EQH N/A
- IPO Year
- INM N/A
- EQH N/A
- Fundamental
- Price
- INM $2.98
- EQH $48.53
- Analyst Decision
- INM
- EQH Buy
- Analyst Count
- INM 0
- EQH 11
- Target Price
- INM N/A
- EQH $60.00
- AVG Volume (30 Days)
- INM 54.4K
- EQH 3.2M
- Earning Date
- INM 05-13-2025
- EQH 04-29-2025
- Dividend Yield
- INM N/A
- EQH 1.89%
- EPS Growth
- INM N/A
- EQH 8.62
- EPS
- INM N/A
- EQH 3.78
- Revenue
- INM $4,832,013.00
- EQH $12,759,000,000.00
- Revenue This Year
- INM N/A
- EQH $25.93
- Revenue Next Year
- INM N/A
- EQH $1.90
- P/E Ratio
- INM N/A
- EQH $13.47
- Revenue Growth
- INM N/A
- EQH 21.33
- 52 Week Low
- INM $1.72
- EQH $36.46
- 52 Week High
- INM $15.70
- EQH $56.00
- Technical
- Relative Strength Index (RSI)
- INM 58.03
- EQH 55.19
- Support Level
- INM $2.85
- EQH $45.10
- Resistance Level
- INM $3.10
- EQH $50.89
- Average True Range (ATR)
- INM 0.25
- EQH 2.03
- MACD
- INM 0.06
- EQH 0.60
- Stochastic Oscillator
- INM 78.44
- EQH 98.63
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.